Table: Hisamitsu -2018/19 parent results
Apr 10 (Reuters)-
Hisamitsu Pharmaceutical Co Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Feb 28, 2019 Feb 28, 2018 Feb 29, 2020 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 109.27 112.51
(-2.9 pct) (-0.2 pct)
Operating 17.79 20.63
(-13.8 pct) (-4.7 pct)
Recurring 19.92 21.37
(-6.8 pct) (-5.9 pct)
Net 15.94 14.62
(+9.0 pct) (-12.7 pct)
EPS 190.96 yen 174.70 yen
EPS Diluted 190.77 yen 174.57 yen
Ann Div 82.50 yen 82.00 yen 83.00 yen
-Q2 Div 41.25 yen 41.00 yen 41.50 yen
-Q4 Div 41.25 yen 41.00 yen 41.50 yen
NOTE - Hisamitsu Pharmaceutical Co Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T
Recent news on Hisamitsu Pharmaceutical Co
See all newsTable: Hisamitsu -2025/26 group results
Table: Hisamitsu -2025/26 parent results
Brief: Hisamitsu Pharmaceutical Co Inc - To Retire Treasury Shares Worth 6.34% Of Outstanding Stock On May 12
Brief: Hisamitsu Pharmaceutical Co Inc - Tender Offer Of Company By Taiyo Kosan Successfully Completed
Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO